June 11, 2020
US Frontotemporal Dementia Market to Witness Healthy Growth Rate until 2025
Increasing funding by government for healthcare sector and growing number of dementia cases to drive United States frontotemporal dementia market According to TechSci Research report, “United States Frontotemporal Dementia Market By Drug Class Type (Antidepressants (Fluoxetine, Fluvoxamine, Sertraline, Paroxetine, Citalopram, Bupropion, Mitrazepine), Antipsychotics (Olanzepine, Quetiapine, Ziprasidone, Aripiprazole, Risperidone, Paliperidone), By Disease Type (Behavior Variant Frontotemporal Dementia (bvFTD), Primary